1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL APHERESIS MARKET, BY PRODUCT
5.1.1 PLASMA SEPARATORS
5.1.2 PLATELETS SEPARATORS
6. GLOBAL APHERESIS MARKET, BY PROCEDURES
7. GLOBAL APHERESIS MARKET, BY METHODS
7.1.1 CONTINUOUS FLOW CENTRIFUGATION
7.1.2 INTERMITTENT FLOW CENTRIFUGATION
8. GLOBAL APHERESIS MARKET, BY APPLICATION
8.1 ONCOLOGICAL DISEASES
8.2 RENAL DISEASES
8.3 CARDIOVASCULAR DISEASES
8.4 HAEMATOLOGICAL DISEASES
8.5 IMMUNOLOGICAL DISEASES
8.6 NEUROLOGICAL DISEASES
9. GLOBAL APHERESIS MARKET, BY END USERS
9.1 BLOOD BANKS
10. GLOBAL APHERESIS MARKET, BY REGION
10.2.1 NORTH AMERICA
10.2.2 SOUTH AMERICA
10.3.1 WESTERN EUROPE
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4.5 REPUBLIC OF KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 UNITED ARAB EMIRATES
10.5.2 SAUDI ARABIA
10.5.6 REST OF MIDDLE EAST & AFRICA
11. COMPETITIVE LANDSCAPE
11.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
11.1.1 STRATEGIC PARTNERSHIP
11.1.2 MERGER & ACQUISITION
12 COMPANY PROFILE
12.1 HAEMONETICS CORPORATION
12.1.2 PRODUCT OVERVIEW
12.1.4 KEY DEVELOPMENTS
12.2 FRESENIUS MEDICAL CARE
12.2.2 PRODUCT OVERVIEW
12.2.4 KEY DEVELOPMENTS
12.3 TERUMO BCT, INC
12.3.2 PRODUCT OVERVIEW
12.3.5 KEY DEVELOPMENT
12.4 ASAHI KASEI MEDICAL CO. LTD
12.4.2 PRODUCT OVERVIEW
12.4.4 KEY DEVELOPMENTS
12.5 HEMACARE CORPORATION
12.5.2 PRODUCT OVERVIEW
12.5.4 KEY DEVELOPMENTS
12.6 B. BRAUN MELSUNGEN AG
12.6.2 PRODUCT OVERVIEW
12.6.4 KEY DEVELOPMENTS
12.7 CERUS CORPORATION
12.7.2 PRODUCT OVERVIEW
12.7.4 KEY DEVELOPMENTS
14.1 KEY FINDINGS
14.1.1 FROM CEO’S VIEWPOINT
14.1.2 UNMET NEEDS OF THE MARKET
14.2 KEY COMPANIES TO WATCH
14.3 PREDICTION OF APHERESIS INDUSTRY
Apheresis market size is expected to grow at a CAGR of 10.2% during the forecast period (2020-2030). Apheresis is a medical procedure that involves the purifying of blood or the separation of distinct blood components. It entails taking blood from a donor or patients and collecting it in a piece of equipment that separates the desired component from the blood while returning the rest to the donor or patients. Two processes were used to separate the components: centrifugation and filtration.
Furthermore, according to the Centers for Disease Control and Prevention (CDC) study, chronic kidney disease affects about 37 million (15%) people in the United States. The Apheresis Market Growth is driven by apheresis, which plays a critical role in the purifying of blood in patients with kidney problems. Along with these considerations, the market Size is being driven forward by increased product innovations and approvals. For example, Fresenius Kabi AG and Fresenius Kabi USA got FDA approval for the ALYX Component Collection System, which is designed to collect and separate whole blood into its constituents in blood collection facilities. As a result of the aforementioned cases shows that the Apheresis Market Trends is predicted to increase steadily over the coming years.
Due to the widespread use of plasma therapy in the treatment of COVID-19 infected patients, the Apheresis Market Growth is predicted to benefit during the COVID-19 pandemic. In addition, the US FDA authorized emergency use authorization (EUA) of convalescent plasma (CCP) therapy in hospitalized COVID-19 patients. Terumo BCT Inc. and Marker Therapeutics AG also gained FDA clearance for the Emergency Use Authorization (EUA) of Terumo BCT's Spectra Optia Apheresis System in combination with Marker Therapeutics' D2000 Adsorption Cartridge to treat COVID-19 disease in patients aged 18 and up. As a result of the widespread use of apheresis units in the treatment of COVID-19 patients and growing FDA product approvals, the Apheresis Market Outlook is on the rise.
Apheresis Market Dynamics
The Apheresis Market Size is fueled by advancements in innovative apheresis procedures, the rising prevalence of various chronic diseases, blood-related ailments, and biopharmaceutical companies' increasing demand for source plasma, among other factors. Increased demand for various blood components, the increasing complexity of surgical operations, and an increase in the number of accidents throughout the world have all contributed to the market's expansion. Acute disseminated encephalomyelitis, autoimmune hemolytic anemia, and cardiac neonatal lupus are among the novel apheresis indications that have recently been approved. The need for platelets is increasing, according to the National Health Service (NHS) Blood and Transplant which will lead to increased Apheresis Market Share during the forecast period.
While a shortage of qualified professionals and the ease with which blood and blood products can be infected, the risk of infection also contributes to the market's slow growth and decreased Apheresis Market Value. However, factors such as the high cost of apheresis devices and therapeutic apheresis procedures, as well as the rental model's installation of apheresis devices, fewer blood donations using apheresis due to lack of awareness, and stringent donor recruitment criteria are expected to limit market growth.
Apheresis is a medical procedure in which a person's blood, whether a donor or a patient, is put through a device that separates a specific ingredient from the rest of the blood and returns it to circulation. Using centrifugation or membrane filtration technology, blood is purified and blood components are separated. This technique is carried out as part of a blood donation or to treat a condition. The apheresis market is divided into two categories based on technology as centrifugation and membrane separation. So, technology plays a vital role in the market.
The report provides a detailed analysis of the apheresis market, including regional growth and competitive analysis based on the market's leading participants and also a detailed review of the market, as well as the many drivers and restraints influencing the market growth.
An in-depth examination of the market's possible segments and sub-segments is provided. The report also includes regional analysis of the market, which includes the Americas, Europe, Asia Pacific, the Middle East, and Africa. It gives insight into the major countries/places where these major businesses are thriving, as well as identifying unexplored regions that could be future markets.
The report keeps track of and assesses competitive trends in the apheresis industry, including joint ventures, strategic alliances, mergers and acquisitions, new product innovations, and research & development.
Apheresis Market Segment Overview
The Global apheresis market is segmented into products, procedures, methods, applications and end user.
Based on the product, the market is segmented as follows:
Based on the procedures, the market is segmented as follows:
Based on the methods, the market is segmented as follows:
Based on the application, the market is segmented as follows:
Based on the end-user, the market is segmented as follows:
Apheresis Market Regional Classification
The Americas have the biggest regional share of the apheresis market. The expansion of this market in the Americas has been fueled by technological advancements, more opportunities for apheresis products, and the existence of a large number of patients suffering from various chronic conditions. The second-largest market is Europe, which is followed by the Asia Pacific. However, Asia Pacific is the market's fastest-growing region. The Asia Pacific apheresis market is growing due to rising demand for various blood components for patients, rapid advancements in healthcare, and rising healthcare expenditure.
The Middle East & Africa
Apheresis Market Competitive Landscape
The industry under consideration is moderately competitive and dominated by a few significant firms; yet, the market is well-established in many areas and has a nascent track record of success. However, in poor countries, its full potential has yet to be determined. People are becoming more conscious as a result of increased government activities, which are fueling the market's rise. The industry is also predicted to grow as a result of strategic agreements and new product launches by key companies. The major key players of the market are as follows:
Terumo BCT (US) cooperated with UniCAR-Therapy Bio-Medicine Technology Co. (China). The goal of this collaboration was to establish a new Shanghai Center of Excellence for CAR T-cell treatments. Terumo was able to expand its apheresis and leukapheresis operations as a result of this advancement.
Fresenius Kabi invested EUR 30 million in the Dominican Republic to expand a transfusion and apheresis disposables plant.
In Goa, the Drugs Controller General of India (DGCI) approved the use of apheresis equipment to recover blood plasma from critically ill COVID-19 patients.
The apheresis market report includes thorough primary research as well as detailed qualitative and quantitative analysis by numerous industry professionals and key opinion leaders to acquire a better understanding of the market and industry performance. The overall report depicts the current market landscape in detail, including historical and projected market size in terms of value and volume, technical advancements, macroeconomic considerations, and market controlling factors. The analysis of the report includes detailed information and plans for the industry's top major players. It also provides an overview of the various market categories and geographies.
|Market Size||2030 : Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Products, Procedures, Methods, Application and End Users|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).|
|Key Market Opportunities||Increasing demand for the different component of the bloods|
|Key Market Drivers||Development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases|
Frequently Asked Questions (FAQ) :
Global Apheresis Market can expand at 9.50% CAGR from 2020 to 2030.
Increasing prevalence of blood diseases and advances in apheresis equipment can drive the Global Apheresis Market.
Lack of skilled professionals and probability of infections with equipment are concerns of the Global Apheresis Market.
Americas can dominate the Global Apheresis Market till 2023.
Kawasumi Laboratories Inc., Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Terumo BCT, Inc., Fresenius Medical Care, Haemonetics Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, HemaCare Corporation, and Therakos, Inc. are major players of the Global Apheresis Market.